Ullmann Claudio Dansky - Aug 1, 2024 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Medical Officer
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Aug 1, 2024
Transactions value $
$0
Form type
4
Date filed
8/1/2024, 05:18 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +202K $0.00 202K Aug 1, 2024 Common Stock 202K $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on August 1, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.